Abstract
Measurement of drugs and their metabolites in biological fluids is the foundation of both therapeutic drug monitoring (TDM) and toxicology. The introduction of methods based on mass spectrometry (MS), coupled with gas or liquid chromatography, has revolutionized these areas. This chapter will introduce the reader to the application of MS to TDM and toxicology, the steps that should be considered during implementation and the processes that should be implemented to assure continued quality. Points of emphasis include advances and recent trends since the publication of the first edition of this book, such as high-resolution mass spectrometry and increased interest in alternate matrices.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
CLSI (2010) Gas chromatography/mass spectrometry confirmation of drugs; approved guideline, 2nd edn. CLSI Document C43-A2. Clinical and Laboratory Standards Institute, Wayne, PA
CLSI (2007) Mass spectrometry in the clinical laboratory: general principles and guidance; approved guideline. CLSI Document C50-A. Clinical and Laboratory Standards Institute, Wayne, PA
Kirchherr H, Kühn-Velten WN (2006) Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. J Chromatogr B Analyt Technol Biomed Life Sci 843:100–113
Zhang Y, Mehrotra N, Budha NR, Christensen ML, Meibohm B (2008) A tandem mass spectrometry assay for the simultaneous determination of acetaminophen, caffeine, phenytoin, ranitidine, and theophylline in small volume pediatric plasma specimens. Clin Chim Acta 398:105–112
Sørensen LK (2010) Determination of acidic and neutral therapeutic drugs in human blood by liquid chromatography-electrospray tandem mass spectrometry. Forensic Sci Int. https://doi.org/10.1016/j.forsciint.2010.07.016
Subramanian M, Birnbaum AK, Remmel RP (2008) High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry. Ther Drug Monit 30:347–356
Nair H, Lawrence L, Hoofnagle AN (2012) Liquid chromatography-tandem mass spectrometry work flow for parallel quantification of methotrexate and other immunosuppressants. Clin Chem 58:943–945
Salm P, Taylor PJ, Rooney F (2008) A high-performance liquid chromatography-mass spectrometry method using a novel atmospheric pressure chemical ionization approach for the rapid simultaneous measurement of tacrolimus and cyclosporin in whole blood. Ther Drug Monit 30:292–300
Koster RA, Dijkers ECF, Uges DRA (2009) Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. Ther Drug Monit 31:116–125
Bogusz MJ et al (2007) Simultaneous LC-MS-MS determination of cyclosporine a, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure. J Chromatogr B Analyt Technol Biomed Life Sci 850:471–480
Vande Casteele N et al (2014) Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives. Curr Gastroenterol Rep 16:378
Wu AH, Gerona R, Armenian P, French D, Petrie M, Lynch KL (2012) Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology. Clin Toxicol (Phila) 50:733–742
Mikel C, Almazan P, West R, Crews B et al (2009) LC-MS/MS extends the range of drug analysis in pain patients. Ther Drug Monit 31:746–748
Centers for Medicare & Medicaid Services (2003) Interpretive guidelines for laboratories. http://www.cms.gov/CLIA/03_Interpretive_Guidelines_for_Laboratories.asp. Accessed 20 Nov 2017
Committee on Identifying the Needs of the Forensic Sciences Community, National Research Council (2009) Strengthening forensic science in the United States: a path forward. The National Academies Press, Washington, D.C.
Kaye DH (2010) The good, the bad, the ugly: the NAS report on strengthening forensic science in America. Sci Justice 50:8–11
United Nations Office on Drugs and Crime (2009) Guidance for the implementation of a quality management system in drug testing laboratories. http://www.unodc.org/documents/scientific/QMS_Ebook.pdf. Accessed 20 Nov 2017
United States Department of Justice Drug Enforcement Administration (2010) Scientific working group for the analysis of seized drugs recommendations. http://www.swgdrug.org/Documents/SWGDRUG%20Recommendations%20Version%207-1.pdf. Accessed 20 Nov 2017
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Snozek, C.L.H., Langman, L.J., Cotten, S.W. (2019). An Introduction to Drug Testing: The Expanding Role of Mass Spectrometry. In: Langman, L., Snozek, C. (eds) LC-MS in Drug Analysis. Methods in Molecular Biology, vol 1872. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8823-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8823-5_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8822-8
Online ISBN: 978-1-4939-8823-5
eBook Packages: Springer Protocols